US-based medical device company Acclaro Corporation has introduced UltraClear, a laser technology system, in the country.

The new device was launched at ASLMS 2022, the 41st annual conference of the American Society for Laser Medicine and Surgery, currently being held in San Diego, California.

UltraClear is powered by cold fibre laser technology and can be used to treat different skin conditions, such as wrinkles, scars and acne scars, pigmentation, enlarged pores, fine lines, and other complexion issues.

The company said that the system is safe for all skin types.

Acclaro co-founder president, chairman and chief technology officer Shlomo Assa, who also invented the UltraClear technology, said: “The 2,910nm wavelength is at water peak absorption and maximises tissue ablation while minimising the incidence of post-inflammatory hyperpigmentation (PIH) or post-inflammatory erythema (PIE), as well as bleeding.

“Fibre lasers are the future of laser technology because they are more reliable with superior beam quality and speed.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Acclaro chief medical officer Eric F Bernstein conducted a histopathology study of the effects of the UltraClear laser with the Main Line Center for Laser Surgery in Ardmore, Pennsylvania. The study has not yet been published.

Bernstein said: “The laser is extremely fast. Depending on the setting, I have treated the full face in four minutes without pain using the 15mm x 15mm spot, which is easy to use.

“Plus, the fact that we don’t need to use topical anaesthetic saves me an hour plus on each patient, which is a huge advantage.”